Lymphoproliferative response and T lymphocyte subsets in a medium-term multi-organ bioassay for carcinogenesis in Wistar rats

Citation
Alt. Spinardi-barbisan et al., Lymphoproliferative response and T lymphocyte subsets in a medium-term multi-organ bioassay for carcinogenesis in Wistar rats, CANCER LETT, 154(2), 2000, pp. 121-129
Citations number
33
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
154
Issue
2
Year of publication
2000
Pages
121 - 129
Database
ISI
SICI code
0304-3835(20000630)154:2<121:LRATLS>2.0.ZU;2-U
Abstract
The lymphoproliferative response and T lymphocyte subsets were evaluated at different stages of carcinogenesis in male Wistar, rats sequentially initi ated with N-diethylnitrosamine (DEN), N-butyl-N-4(hydroxybutyl)nitrosamine (BBN), N-methyl-N-nitrosourea (MNU), dihydroxy-di-N-propylnitrosamine (DHPN ) and N,N'-dimethylhydrazine (DMH) (DMBDD initiation). One group was evalua ted at the 4th week and other initiated group at the 30th week. Two initiat ed groups were also exposed through diet to 7-acetylaminofluorene (2-AAF) o r phenobarbital (PB), from the 6th until the 30th week. Two groups received only 2-AAF or PB until the 30th week. Five groups were studied to evaluate the effects of each initiator. The lymphoproliferative response was induce d in vitro by concanavalin A and the percentage of T lymphocyte subsets was determined by flow cytometry, All groups submitted to initiation only, ini tiation plus promotion, or promotion only, developed significantly more pre neoplastic: lesions than the untreated control group. The main target organ s for tumor development were the liver, colon, urinary bladder, kidneys and Zymbal glands, mainly in the group treated with DMBDD + 2-AAF, There were no alterations of the lymphoproliferative response and of the T lymphocyte subsets percentage in the DMBDD-treated group at the 4th and 30th weeks. At the 30th week, the T lymphocyte subsets percentage was also not affected i n the initiated groups after treatments with 2-AAF or PB. The lymphoprolife rative response, however, was decreased in the DMBDD + 2-AAF group and in t he groups treated only with 2-AAF or PB, The present results indicate that the initiating chemicals used in the DMBDD initiation protocol do not exert any influence on the immune system. The alteration of lymphoproliferative response induced at the advanced stage of carcinogenesis without alteration of T lymphocyte subsets may indicate that the influence of 2-AAF and PB on the immune system is functional and not toxic. (C) 2000 Elsevier Science I reland Ltd. All rights reserved.